Nathan Clumeck - Publications

Dynamics of SARS-CoV-2 RT-PCR positivity and seroprevalence among high-risk healthcare workers and hospital staff.

Journal: The Journal of hospital infection

Published: June 11, 2020

Meropenem-clavulanate for drug-resistant tuberculosis: a follow-up of relapse-free cases.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: January 04, 2018

Professional fatigue syndrome (burnout) : Part 2 : from therapeutic management

Journal: Revue medicale de Liege

Published: June 20, 2017

Professional fatigue syndrome (burnout). Part 1 : identification by the general practitioner

Journal: Revue medicale de Liege

Published: May 19, 2017

Isolation unit for multidrug-resistant tuberculosis patients in a low endemic country, a step towards the World Health Organization End TB Strategy.

Journal: Epidemiology and infection

Published: February 17, 2017

Limited HIV-1 Reactivation in Resting CD4+ T cells from Aviremic Patients under Protease Inhibitors.

Journal: Scientific reports

Published: September 20, 2016

Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study.

Journal: The Lancet. Infectious diseases

Published: September 09, 2016

Brief Report: A Randomized, Double-Blind Comparison of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate, Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine for Initial HIV-1 Treatment: Week 96 Results.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: February 02, 2016

High-risk human papillomavirus genotypes distribution in a cohort of HIV-positive women living in Europe: epidemiological implication for vaccination against human papillomavirus.

Journal: AIDS (London, England)

Published: January 15, 2016

Sequential treatment with 5-aza-2'-deoxycytidine and deacetylase inhibitors reactivates HIV-1.

Journal: EMBO molecular medicine

Published: December 19, 2015

Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: December 10, 2015

Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial.

Journal: The lancet. HIV

Published: December 01, 2015